Dr. Steinhaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Park Ave
Minneapolis, MN 55415Phone+1 763-514-3577- Is this information wrong?
Education & Training
- Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 1983 - 1984
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1980 - 1983
- Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1980
- Harvard Medical SchoolClass of 1977
Certifications & Licensure
- MN State Medical License 2006 - 2025
- MO State Medical License 1984 - 2025
- KS State Medical License 1996 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- AdaptResponse Clinical Trial Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 11 citationsCurrent state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillator.Massimo Santini, Riccardo Cappato, Dietrich Andresen, Johannes Brachmann, D. Wyn Davies, John G.F. Cleland, Alessandro Filippi, Edoardo Gronda, Richard N.W. Hauer, Ger...> ;Journal of Interventional Cardiac Electrophysiology. 2009 Mar 6
- Fifty Years of Pacemaker AdvancementsDavid Steinhaus> ;Journal of Cardiovascular Translational Research. 2008 Nov 4
- 12 citationsIncreased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: Insights from the atrial overdrive pacing studyBharat K. Kantharia, Roger A. Freedman, David Hoekenga, Gery Tomassoni, Seth J. Worley, Robert A. Sorrentino, David Steinhaus, Joel M. Wolkowicz, Zaffer A. Syed> ;Europace. 2007 Nov 1
- Join now to see all
Press Mentions
- Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA ApprovalAugust 9th, 2018
- Medtronic, United Receive Approval for Fully Implantable PAH Infusion PumpAugust 1st, 2018
- FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAHAugust 1st, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: